semaglutide and ckd just got FDA-approved for kidney disease. This changes everything., January 2025. The FDA approved semaglutide (Ozempic/Wegovy) for a new indication: reducing kidney disease progression in Effectiveness of semaglutide on survival

Treat other underlying conditions Maselli reminds people that obesity and overweight can put individuals at risk for more than 200 conditions, including hypertension and type 2 diabetes

*Correspondence: Gbor Gullner, [email protected] These authors have contributed equally to this work and share first authorship This article was submitted to Plant Microbe Interactions, a section of the journal Frontiers in Plant Science Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers

Regardless of the potential of anti-inflammatory properties of GLP-1 receptor agonists [61] and SGLT2 inhibitors [62] to ameliorate hearing impairment [7,8,9,63], this physiopathology might not be able to reverse the potential ototoxicity effect mentioned above

The real problems lie in the complete lack of data about what happens if you take these drugs before and during conception, and what the impact on the fetus might be